Macular Disease Foundation1 Australia (MDFA) has appointed Professor Sanchia Aranda AM as its new Chair, following Graeme Head AO stepping down after four years in the role.

Prof Aranda brings extensive expertise across health, education, research, disability and the for-purpose sector. She has led organisational transformation, strengthened governance, championed consumer involvement in cancer research, and is highly experienced in leading public education campaigns.

Currently Chair of Scope Australia and the Victorian Comprehensive Cancer Centre Alliance, Prof Aranda began her career in nursing, and was the first nurse to lead Cancer Council Australia as CEO.

With a strong family history of age-related macular degeneration, that affected both parents, she is passionate about contributing to changing public understanding of macular disease.

Stepping into the role, Prof Aranda thanked Graeme Head AO for his outstanding leadership and steady stewardship of MDFA. His departure coincided with his appointment as the new CEO of the National Disability Insurance Agency (NDIA) in November this year.

“Macular Disease Foundation and fellow Board members sincerely thank Graeme for his commitment and guidance, which have strengthened our organisation and its support for the macular disease community,” said MDFA CEO, Dr Kathy Chapman. “Professor Aranda’s leadership will be pivotal as we advance research, advocacy, and improve outcomes for Australians living with macular disease.”

Professor Aranda joined the MDFA Board earlier in 2025 and was appointed Chair in December.